Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.
2.

Human Agency in Disaster Planning: A Systems Approach.

Powell JH, Hammond M, Chen A, Mustafee N.

Risk Anal. 2018 Jul;38(7):1422-1443. doi: 10.1111/risa.12958. Epub 2018 Jan 16.

PMID:
29341200
3.

Candidate adaptive genes associated with lineage divergence: identifying SNPs via next-generation targeted resequencing in mule deer (Odocoileus hemionus).

Powell JH, Amish SJ, Haynes GD, Luikart G, Latch EK.

Mol Ecol Resour. 2016 Sep;16(5):1165-72. doi: 10.1111/1755-0998.12572. Epub 2016 Aug 12.

PMID:
27438092
4.

A parameter to quantify the degree of genetic mixing among individuals in hybrid populations.

Kalinowski ST, Powell JH.

Heredity (Edinb). 2015 Mar;114(3):249-54. doi: 10.1038/hdy.2014.93. Epub 2014 Nov 12.

5.
6.

The population history of endogenous retroviruses in mule deer (Odocoileus hemionus).

Kamath PL, Elleder D, Bao L, Cross PC, Powell JH, Poss M.

J Hered. 2014 Mar-Apr;105(2):173-87. doi: 10.1093/jhered/est088. Epub 2013 Dec 13.

7.

Default mode network functional and structural connectivity after traumatic brain injury.

Sharp DJ, Beckmann CF, Greenwood R, Kinnunen KM, Bonnelle V, De Boissezon X, Powell JH, Counsell SJ, Patel MC, Leech R.

Brain. 2011 Aug;134(Pt 8):2233-47. doi: 10.1093/brain/awr175.

PMID:
21841202
8.

Growth and long-term somatic and germline chimerism following fusion of juvenile Botryllus schlosseri.

Carpenter MA, Powell JH, Ishizuka KJ, Palmeri KJ, Rendulic S, De Tomaso AW.

Biol Bull. 2011 Feb;220(1):57-70.

9.

White matter damage and cognitive impairment after traumatic brain injury.

Kinnunen KM, Greenwood R, Powell JH, Leech R, Hawkins PC, Bonnelle V, Patel MC, Counsell SJ, Sharp DJ.

Brain. 2011 Feb;134(Pt 2):449-63. doi: 10.1093/brain/awq347. Epub 2010 Dec 29.

10.

Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence.

Dawkins L, Powell JH, Pickering A, Powell J, West R.

Addiction. 2009 May;104(5):850-8. doi: 10.1111/j.1360-0443.2009.02522.x. Epub 2009 Mar 13.

11.

The project IMPACT experience to date: increasing minority participation and awareness of clinical trials.

Powell JH, Fleming Y, Walker-McGill CL, Lenoir M.

J Natl Med Assoc. 2008 Feb;100(2):178-87.

PMID:
18300535
12.

A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning.

Dawkins L, Powell JH, West R, Powell J, Pickering A.

Psychopharmacology (Berl). 2007 Mar;190(4):457-67. Epub 2007 Jan 5.

PMID:
17205318
13.

A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.

Dawkins L, Powell JH, West R, Powell J, Pickering A.

Psychopharmacology (Berl). 2006 Dec;189(3):355-67. Epub 2006 Oct 18.

PMID:
17047930
14.
15.

Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxin.

Toothaker RD, Corey AE, Valentine SN, Agnew JR, Parekh N, Moehrke W, Thompson GA, Powell JH.

J Clin Pharmacol. 2005 Jul;45(7):773-80.

PMID:
15951467
16.

Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation.

Powell JH, Pickering AD, Dawkins L, West R, Powell JF.

Addict Behav. 2004 Sep;29(7):1407-26.

PMID:
15345273
17.

Effect of mild and moderate hepatic impairment on azimilide pharmacokinetics following single dose oral administration.

Corey AE, Agnew JR, King EC, Parekh NJ, Powell JH, Thompson GA.

J Pharm Sci. 2004 May;93(5):1279-86.

PMID:
15067704
18.

Effects of cigarette smoking on reward responsivity and cognitive function in brain injured individuals.

Richardson M, Powell JH, Curran HV.

Neuropsychol Rehabil. 2003 Jul;13(3):365-78. doi: 10.1080/09602010343000011.

PMID:
21854318
19.

Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration.

Corey AE, Agnew JR, Valentine SN, Parekh NJ, Powell JH, Thompson GA.

Br J Clin Pharmacol. 2002 Nov;54(5):449-52.

20.

A challenge to the makers of pharmaceuticals.

Powell JH, Harrison RW, LeNoir MA.

J Natl Med Assoc. 2002 Oct;94(10):870-2. No abstract available.

21.

Mechanisms of carcinogenicity of aryl hydrazines, aryl hydrazides, and arenediazonium ions.

Powell JH, Gannett PM.

J Environ Pathol Toxicol Oncol. 2002;21(1):1-31. Review.

PMID:
11934010
22.

Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systems.

Buch AB, Shen LZ, Kelly SC, Russell DA, Sahota RS, Bixler CA, Moehrke W, Powell JH.

Climacteric. 1999 Dec;2(4):248-53.

PMID:
11910658
23.
24.

Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration.

Mitchell DY, Barr WH, Eusebio RA, Stevens KA, Duke FP, Russell DA, Nesbitt JD, Powell JH, Thompson GA.

Pharm Res. 2001 Feb;18(2):166-70.

PMID:
11405286
25.
26.

Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochloride.

Toothaker RD, Barker SH, Gillen MV, Helsinger SA, Kindberg CG, Hunt TL, Powell JH.

Biopharm Drug Dispos. 2000 Sep;21(6):229-33.

PMID:
11304721
27.

The effect of aerobic training on rehabilitation outcomes after recent severe brain injury: a randomized controlled evaluation.

Bateman A, Culpan FJ, Pickering AD, Powell JH, Scott OM, Greenwood RJ.

Arch Phys Med Rehabil. 2001 Feb;82(2):174-82.

PMID:
11239307
28.

Making medicines for America: the case for clinical trial diversity.

Powell JH, Fleming Y.

J Natl Med Assoc. 2000 Nov;92(11):507-14. No abstract available.

29.

Comparative oral bioavailability of azimilide dihydrochloride in the fed and fasted states.

Corey AE, Agnew JR, Valentine SN, Nesbitt JD, Wagner DL, Powell JH, Thompson GA.

Br J Clin Pharmacol. 2000 Mar;49(3):279-82.

30.

Effect of renal function on risedronate pharmacokinetics after a single oral dose.

Mitchell DY, St Peter JV, Eusebio RA, Pallone KA, Kelly SC, Russell DA, Nesbitt JD, Thompson GA, Powell JH.

Br J Clin Pharmacol. 2000 Mar;49(3):215-22.

31.

Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers.

Mitchell DY, Eusebio RA, Sacco-Gibson NA, Pallone KA, Kelly SC, Nesbitt JD, Brezovic CP, Thompson GA, Powell JH.

J Clin Pharmacol. 2000 Mar;40(3):258-65.

PMID:
10709154
32.

Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation.

Corey AE, Agnew JR, Valentine SN, Nesbitt JD, Wagner DL, Powell JH, Thompson GA.

J Clin Pharmacol. 1999 Dec;39(12):1272-6.

PMID:
10586393
33.

The differential optomotor response of the four-eyed fish Anableps anableps.

Albensi BC, Powell JH.

Perception. 1998;27(12):1475-83.

PMID:
10505191
34.

C8-Arylguanine and C8-aryladenine formation in calf thymus DNA from arenediazonium ions.

Gannett PM, Powell JH, Rao R, Shi X, Lawson T, Kolar C, Toth B.

Chem Res Toxicol. 1999 Mar;12(3):297-304.

PMID:
10077493
36.

Motivational deficits after brain injury: a neuropsychological approach using new assessment techniques.

al-Adawi S, Powell JH, Greenwood RJ.

Neuropsychology. 1998 Jan;12(1):115-24.

PMID:
9460739
37.

Assessment of doxylamine influence on mixed function oxidase activity upon multiple dose oral administration to normal volunteers.

Thompson GA, St Peter JV, Heise MA, Horowitz ZD, Salyers GC, Charles TT, Brezovic C, Russell DA, Skare JA, Powell JH.

J Pharm Sci. 1996 Nov;85(11):1242-7.

PMID:
8923333
38.

Motivational deficits after brain injury: effects of bromocriptine in 11 patients.

Powell JH, al-Adawi S, Morgan J, Greenwood RJ.

J Neurol Neurosurg Psychiatry. 1996 Apr;60(4):416-21.

39.

Safety assessment of OTC drugs: doxylamine succinate.

Skare JA, Murphy VA, Bookstaff RC, Thompson GA, Heise MA, Horowitz ZD, Powell JH, Parkinson A, St Peter JV.

Arch Toxicol Suppl. 1995;17:326-40. Review. No abstract available.

PMID:
7786169
40.

Use of mesalamine and olsalazine in ulcerative colitis.

Gait JE, Powell JH, Regalli G.

Am Fam Physician. 1993 Nov 15;48(7):1234, 1236. No abstract available.

PMID:
8237737
41.

Photographic cockpit model for prescribing multifocals.

Powell JH.

Mil Med. 1992 Jan;157(1):15-6.

PMID:
1603370
42.

Antipyretic activity of tebufelone (NE-11740) in man.

Powell JH, Meredith MP, Vargas R, McMahon FG, Jain AK.

Agents Actions Suppl. 1991;32:45-9.

PMID:
2069096
43.

Effects of venous hypertension on rabbit free flap survival.

Rooks MD, Gould JS, Masear V, Powell JH 3rd, Gould S.

Microsurgery. 1991;12(4):253-61.

PMID:
1895934
44.

Application of liquid chromatography with on-line radiochemical detection to metabolism studies on a novel class of analgesics.

Wehmeyer KR, Kasting GB, Powell JH, Kuhlenbeck DL, Underwood RA, Bowman LA.

J Pharm Biomed Anal. 1990;8(2):177-83.

PMID:
2094417
45.

The reflective practitioner in nursing.

Powell JH.

J Adv Nurs. 1989 Oct;14(10):824-32.

PMID:
2808937
46.

Osteochondritis dissecans of the talus.

Powell JH 3rd, Whipple TL.

Foot Ankle. 1986 Jun;6(6):309-10.

PMID:
3721368
47.

Techniques of wrist arthroscopy.

Whipple TL, Marotta JJ, Powell JH 3rd.

Arthroscopy. 1986;2(4):244-52.

PMID:
3801103
48.

In vitro response of hepatic lysosomes to endogenous and exogenous cationic compounds.

Powell JH, Reidenberg MM.

Proc Soc Exp Biol Med. 1984 Sep;176(4):346-9.

PMID:
6463045
49.

Further studies of the response of kidney lysosomes to aminoglycosides and other cations.

Powell JH, Reidenberg MM.

Biochem Pharmacol. 1983 Nov 1;32(21):3213-20.

PMID:
6639687
50.

In vitro response of rat and human kidney lysosomes to aminoglycosides.

Powell JH, Reidenberg MM.

Biochem Pharmacol. 1982 Nov 1;31(21):3447-53. No abstract available.

PMID:
7150364

Supplemental Content

Loading ...
Support Center